Effect of Externally Implantable Tissue Expansion Device on Scar Length

This study has been withdrawn prior to enrollment.
(Inability to recruit eligible subjects)
Sponsor:
Information provided by (Responsible Party):
Murad Alam, Northwestern University
ClinicalTrials.gov Identifier:
NCT00798798
First received: November 24, 2008
Last updated: February 7, 2012
Last verified: February 2012

November 24, 2008
February 7, 2012
April 2008
October 2010   (final data collection date for primary outcome measure)
Surface area (in cm2) of subject's scar [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00798798 on ClinicalTrials.gov Archive Site
Treating physicians will note any adverse effects [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Effect of Externally Implantable Tissue Expansion Device on Scar Length
Effect of Externally Implantable Tissue Expansion Device on Scar Length

The purpose of this study is to assess whether brief use of an externally implantable tissue expansion device following excisional skin cancer surgery will significantly reduce the diameter of the final wound defect, and hence the length of the final linear primary closure. The secondary objective is to assess the functional benefits, if any, associated with use of the tissue expander.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Skin Lesion
Device: Externally Implantable Tissue Expansion Device
Will Apply Externally Implantable Tissue Expansion Device for 2 Days
Experimental: Implantable Tissue Expansion Device
Will apply externally implantable tissue expansion device for 2 days
Intervention: Device: Externally Implantable Tissue Expansion Device
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
October 2010
October 2010   (final data collection date for primary outcome measure)

Inclusion Criteria

  • Subjects ages 18-80 years old
  • Subjects who are undergoing an excision of a large cutaneous lesion
  • Subjects with an immediate post-excision wound defect at least 2.5 cm in diameter
  • Subjects undergoing surgery on the trunk or extremities
  • The subject has willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
  • Subjects who are willing to undergo no other treatments for the scars for the duration of the study.

Exclusion Criteria

  • Subjects with scalp wounds
  • Subjects who are unable to understand the protocol or give informed consent
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00798798
MA-STU2545
No
Murad Alam, Northwestern University
Northwestern University
Not Provided
Study Director: Dennis P West, PhD Northwestern University
Principal Investigator: Murad Alam, MD Northwestern University
Northwestern University
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP